Cancers Exceptional Reviewers List 2026

We are absolutely delighted to present the updated Exceptional Reviewers List for 2026—a special recognition program designed to honor those scholars who have consistently delivered outstanding, insightful, and meticulous review reports for Cancers (ISSN: 2072-6694).

At Cancers, we are deeply committed to advancing rigorous scientific research and fostering meaningful knowledge exchange. Our reviewers are the unsung heroes of scholarly publishing, and their contributions are indispensable to maintaining the high quality, integrity, and credibility of every article we publish.

We would like to express our heartfelt thanks to all reviewers who have generously volunteered their time, expertise, and thoughtful attention to evaluate manuscripts, provide constructive feedback, and help shape the final published work. Their dedication to academic rigor and collegial support is truly inspiring and commendable.

The Exceptional Reviewers List was launched in April 2026 as a quarterly initiative. Each quarter, we select a new group of reviewers and feature them here. We invite our readers and the broader research community to join us in celebrating these exceptional individuals.

Q1:
Name: Dr. Lilia Matei
Affiliation: Department of Cellular and Molecular Pathology, Stefan S. Nicolau Institute of Virology, 030304 Bucharest, Romania
Interests: medicinal chemistry; bioactive compound synthesis; natural products; structure–activity relationships; immune responses to viral infections; antiviral drugs; cancer progression and metastasis; anticancer drugs

Name: Dr. Ashutosh Vashisht
Affiliation: Department of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA
Interests: molecular pathology; translational cancer research
“Peer review is an opportunity to uphold scientific rigor and improve research quality. I greatly value MDPI’s efficient editorial process and transparent policies, which support fair, timely, and constructive reviews.”

Name: Dr. Zoard T. Krasznai
Affiliation: Department of Obstetrics and Gynecology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary
Interests: clinical oncology; gynecological oncology; gyneco-oncology surgery; HPV

Name: Dr. Petra Valković Zujić
Affiliation: Department of Diagnostic and Interventional Radiology, Clinical Hospital Centre Rijeka, Krešimirova 42, 51000 Rijeka, Croatia
Interests: breast cancer; contrast-enhanced mammography; magnetic resonance imaging

Name: Dr. Hernando Lopez-Bertoni
Affiliation: ¹ Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD, USA
² Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Interests: brain tumors; tumor microenvironment; miRNAs; molecular therapies; cancer stem cells; epigenetics; nanomedicine; cellular transitions; IND-enabling studies; therapy resistance

Q2:
Name: Dr. Sabela Paradela
Affiliation: Dermatology Department, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain
Interests: melanoma; prevention; life

Name: Dr. Tomohiro Matsuo
Affiliation: Department of Urology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
Interests: urology; bladder; oncology; overactive bladder; benign prostatic hyperplasia
“Peer review is an important academic responsibility, and I always try to provide constructive comments that help improve the quality and clinical value of manuscripts.”

Name: Dr. Jing Yuan
Affiliation: Research Department, Hong Kong Sanatorium & Hospital, Happy Valley, Hong Kong SAR, China
Interests: MRI; MR-guided radiotherapy; medical imaging

Name: Dr. Karolina Lisy
Affiliation: Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, Australia
Interests: colorectal cancer; systematic review; quality of life; models of care; survivorship

Name: Dr. Mark Hartmann
Affiliation: Section of Translational Cancer Epigenomics, Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Interests: molecular biology; epigenetics; stem cell biology; hematopoiesis; circulating tumor cells

Q3:
Name: Dr. Lisbeth Barkholt
Affiliation: Karolinska Institutet, Inst. LabMed, Sweden
Interests: stem cell transplantation; transplantation immunology, liver transplantation, renal cell cancer, advanced medicine products, clinical trials and regulatory medicine
“Reviewing scientific manuscripts in medicine and development of medicinal products is stimulating work to support the activities required to preserve high quality of research and publication of research outcome. Combined efforts by reviewers having various angels when studying manuscripts will lead to overall evaluation that should be valuable for authors to improve a manuscript and their skills in the future work. Some weak elements I've noticed are to present a hypothesis and ability to systematically discuss used methodology and results to conclude without overestimation. My private benefit is to keep me updated on the progress at the field of my main interests.”

Name: Dr. Hao Huang
Affiliation: Northwestern University Feinberg School of Medicine, Chicago, United States
Interests: ovarian cancer; epitranscriptomic; oncology; omics

Name: Prof. Dr. Sarah E. Coupland
Affiliation: Liverpool Ocular Oncology Research Group, Department of Molecular and Clinical Cancer Medicine, Institute of Translational Medicine, University of Liverpool, Liverpool L7 8TX, UK
Interests: cancer; melanoma; lymphoma; molecular pathology; diagnostics

Name: Dr. Prapaporn Suprasert
Affiliation: Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
Interests: gynecologic oncology
“Peer review allows me to contribute to scientific quality and learn from new research. I value providing constructive feedback that helps authors strengthen their work.”

Name: Dr. Byungwook Choi
Affiliation: Department of Nuclear Medicine, School of Medicine, Daegu Catholic University, Daegu 42472, South Korea
Interests: radiation protection; oncological nuclear medicine; isotope therapy